{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:04:58Z","timestamp":1794668698011,"version":"4.9.1"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41574-023-00855-y","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T08:04:04Z","timestamp":1687766644000},"page":"507-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Targeting the central melanocortin system for the treatment of metabolic disorders"],"prefix":"10.1038","volume":"19","author":[{"given":"Patrick","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0110-2135","authenticated-orcid":false,"given":"Luis E.","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciria C.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3333-5651","authenticated-orcid":false,"given":"Roger D.","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"855_CR1","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1016\/S0021-9258(18)53088-X","volume":"268","author":"I Gantz","year":"1993","unstructured":"Gantz, I. et al. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246\u20138250 (1993).","journal-title":"J. Biol. Chem."},{"key":"855_CR2","doi-asserted-by":"crossref","first-page":"15174","DOI":"10.1016\/S0021-9258(18)82452-8","volume":"268","author":"I Gantz","year":"1993","unstructured":"Gantz, I. et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268, 15174\u201315179 (1993).","journal-title":"J. Biol. Chem."},{"key":"855_CR3","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.90.19.8856","volume":"90","author":"L Roselli-Rehfuss","year":"1993","unstructured":"Roselli-Rehfuss, L. et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl Acad. Sci. USA 90, 8856\u20138860 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1325670","volume":"257","author":"KG Mountjoy","year":"1992","unstructured":"Mountjoy, K. G., Robbins, L. S., Mortrud, M. T. & Cone, R. D. The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248\u20131251 (1992).","journal-title":"Science"},{"key":"855_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4419-6354-3_3","volume":"681","author":"KG Mountjoy","year":"2010","unstructured":"Mountjoy, K. G. Distribution and function of melanocortin receptors within the brain. Adv. Exp. Med. Biol. 681, 29\u201348 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"855_CR6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","volume":"8","author":"RD Cone","year":"2005","unstructured":"Cone, R. D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571\u2013578 (2005).","journal-title":"Nat. Neurosci."},{"key":"855_CR7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2174\/156802607780906681","volume":"7","author":"AM Shadiack","year":"2007","unstructured":"Shadiack, A. M., Sharma, S. D., Earle, D. C., Spana, C. & Hallam, T. J. Melanocortins in the treatment of male and female sexual dysfunction. Curr. Top. Med. Chem. 7, 1137\u20131144 (2007).","journal-title":"Curr. Top. Med. Chem."},{"key":"855_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1054\/npep.2002.0890","volume":"36","author":"AA Butler","year":"2002","unstructured":"Butler, A. A. & Cone, R. D. The melanocortin receptors: lessons from knockout models. Neuropeptides 36, 77\u201384 (2002).","journal-title":"Neuropeptides"},{"key":"855_CR9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/er.2006-0034","volume":"27","author":"RD Cone","year":"2006","unstructured":"Cone, R. D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 27, 736\u2013749 (2006).","journal-title":"Endocr. Rev."},{"key":"855_CR10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","volume":"91","author":"W Chen","year":"1997","unstructured":"Chen, W. et al. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91, 789\u2013798 (1997).","journal-title":"Cell"},{"key":"855_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","volume":"278","author":"MM Ollmann","year":"1997","unstructured":"Ollmann, M. M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by Agouti-related protein. Science 278, 135\u2013138 (1997).","journal-title":"Science"},{"key":"855_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","volume":"385","author":"W Fan","year":"1997","unstructured":"Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. & Cone, R. D. Role of melanocortinergic neurons in feeding and the Agouti obesity syndrome. Nature 385, 165\u2013168 (1997).","journal-title":"Nature"},{"key":"855_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","volume":"88","author":"D Huszar","year":"1997","unstructured":"Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131\u2013141 (1997).","journal-title":"Cell"},{"key":"855_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/jne.12285","volume":"27","author":"KG Mountjoy","year":"2015","unstructured":"Mountjoy, K. G. Pro-opiomelanocortin (POMC) neurones, POMC-derived peptides, melanocortin receptors and obesity: how understanding of this system has changed over the last decade. J. Neuroendocrinol. 27, 406\u2013418 (2015).","journal-title":"J. Neuroendocrinol."},{"key":"855_CR15","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-14-0405","volume":"223","author":"J Friedman","year":"2014","unstructured":"Friedman, J. 20 years of leptin: leptin at 20: an overview. J. Endocrinol. 223, T1\u2013T8 (2014).","journal-title":"J. Endocrinol."},{"key":"855_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnins.2013.00019","volume":"7","author":"AJ Mercer","year":"2013","unstructured":"Mercer, A. J., Hentges, S. T., Meshul, C. K. & Low, M. J. Unraveling the central proopiomelanocortin neural circuits. Front. Neurosci. 7, 19 (2013).","journal-title":"Front. Neurosci."},{"key":"855_CR17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuron.2017.06.014","volume":"95","author":"ML Andermann","year":"2017","unstructured":"Andermann, M. L. & Lowell, B. B. Toward a wiring diagram understanding of appetite control. Neuron 95, 757\u2013778 (2017).","journal-title":"Neuron"},{"key":"855_CR18","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1523\/JNEUROSCI.4861-12.2014","volume":"34","author":"SB Baver","year":"2014","unstructured":"Baver, S. B. et al. Leptin modulates the intrinsic excitability of AgRP\/NPY neurons in the arcuate nucleus of the hypothalamus. J. Neurosci. 34, 5486\u20135496 (2014).","journal-title":"J. Neurosci."},{"key":"855_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-018-0049-7","volume":"556","author":"J Xu","year":"2018","unstructured":"Xu, J. et al. Genetic identification of leptin neural circuits in energy and glucose homeostases. Nature 556, 505\u2013509 (2018).","journal-title":"Nature"},{"key":"855_CR20","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/endo.138.10.5570","volume":"138","author":"CC Cheung","year":"1997","unstructured":"Cheung, C. C., Clifton, D. K. & Steiner, R. A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138, 4489\u20134492 (1997).","journal-title":"Endocrinology"},{"key":"855_CR21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/35078085","volume":"411","author":"MA Cowley","year":"2001","unstructured":"Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480\u2013484 (2001).","journal-title":"Nature"},{"key":"855_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nn.4202","volume":"19","author":"MJ Krashes","year":"2016","unstructured":"Krashes, M. J., Lowell, B. B. & Garfield, A. S. Melanocortin-4 receptor-regulated energy homeostasis. Nat. Neurosci. 19, 206\u2013219 (2016).","journal-title":"Nat. Neurosci."},{"key":"855_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"Krude, H. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155\u2013157 (1998).","journal-title":"Nat. Genet."},{"key":"855_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/2404","volume":"20","author":"GS Yeo","year":"1998","unstructured":"Yeo, G. S. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111\u2013112 (1998).","journal-title":"Nat. Genet."},{"key":"855_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI9397","volume":"106","author":"IS Farooqi","year":"2000","unstructured":"Farooqi, I. S. et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 106, 271\u2013279 (2000).","journal-title":"J. Clin. Invest."},{"key":"855_CR26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","volume":"348","author":"IS Farooqi","year":"2003","unstructured":"Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085\u20131095 (2003).","journal-title":"N. Engl. J. Med."},{"key":"855_CR27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","volume":"83","author":"LA Tartaglia","year":"1995","unstructured":"Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263\u20131271 (1995).","journal-title":"Cell"},{"key":"855_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425\u2013432 (1994).","journal-title":"Nature"},{"key":"855_CR29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.140","volume":"40","author":"RJ Loos","year":"2008","unstructured":"Loos, R. J. et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40, 768\u2013775 (2008).","journal-title":"Nat. Genet."},{"key":"855_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152706777452290","volume":"5","author":"RA Adan","year":"2006","unstructured":"Adan, R. A. & van Dijk, G. Melanocortin receptors as drug targets for disorders of energy balance. CNS Neurol. Disord. Drug Targets 5, 251\u2013261 (2006).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"855_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(00)00537-9","volume":"405","author":"RA Adan","year":"2000","unstructured":"Adan, R. A. & Gispen, W. H. Melanocortins and the brain: from effects via receptors to drug targets. Eur. J. Pharmacol. 405, 13\u201324 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"855_CR32","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2017.03.020","volume":"1863","author":"MD Ericson","year":"2017","unstructured":"Ericson, M. D. et al. Bench-top to clinical therapies: a review of melanocortin ligands from 1954 to 2016. Biochim. Biophys. Acta 1863, 2414\u20132435 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"855_CR33","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.bbadis.2017.04.010","volume":"1863","author":"LK Yang","year":"2017","unstructured":"Yang, L. K. & Tao, Y. X. Biased signaling at neural melanocortin receptors in regulation of energy homeostasis. Biochim. Biophys. Acta 1863, 2486\u20132495 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"855_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmet.2018.08.006","volume":"17","author":"P Kirwan","year":"2018","unstructured":"Kirwan, P. et al. Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for \u03b2-MSH and desacetyl \u03b1-MSH in energy homeostasis. Mol. Metab. 17, 82\u201397 (2018).","journal-title":"Mol. Metab."},{"key":"855_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molmet.2017.11.008","volume":"9","author":"KG Mountjoy","year":"2018","unstructured":"Mountjoy, K. G. et al. Desacetyl-\u03b1-melanocyte stimulating hormone and \u03b1-melanocyte stimulating hormone are required to regulate energy balance. Mol. Metab. 9, 207\u2013216 (2018).","journal-title":"Mol. Metab."},{"key":"855_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2006.01.006","volume":"3","author":"YS Lee","year":"2006","unstructured":"Lee, Y. S. et al. A POMC variant implicates \u03b2-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3, 135\u2013140 (2006).","journal-title":"Cell Metab."},{"key":"855_CR37","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1172\/JCI62543","volume":"122","author":"VF Bumaschny","year":"2012","unstructured":"Bumaschny, V. F. et al. Obesity-programmed mice are rescued by early genetic intervention. J. Clin. Invest. 122, 4203\u20134212 (2012).","journal-title":"J. Clin. Invest."},{"key":"855_CR38","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1523\/JNEUROSCI.2742-12.2013","volume":"33","author":"C Zhan","year":"2013","unstructured":"Zhan, C. et al. Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J. Neurosci. 33, 3624\u20133632 (2013).","journal-title":"J. Neurosci."},{"key":"855_CR39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cmet.2018.07.017","volume":"28","author":"G D\u2019Agostino","year":"2018","unstructured":"D\u2019Agostino, G. et al. Nucleus of the solitary tract serotonin 5-HT2C receptors modulate food intake. Cell Metab. 28, 619\u2013630 (2018).","journal-title":"Cell Metab."},{"key":"855_CR40","first-page":"40","volume":"9","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons. Front. Neuroanat. 9, 40 (2015).","journal-title":"Front. Neuroanat."},{"key":"855_CR41","first-page":"1298","volume":"8","author":"KG Mountjoy","year":"1994","unstructured":"Mountjoy, K. G., Mortrud, M. T., Low, M. J., Simerly, R. B. & Cone, R. D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298\u20131308 (1994).","journal-title":"Mol. Endocrinol."},{"key":"855_CR42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00060793-199400010-00016","volume":"1","author":"MJ Low","year":"1994","unstructured":"Low, M. J., Simerly, R. B. & Cone, R. D. Receptors for the melanocortin peptides in the central nervous system. Curr. Opin. Endocrinol. Diabetes Obes. 1, 79\u201388 (1994).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"855_CR43","doi-asserted-by":"crossref","first-page":"RC26","DOI":"10.1523\/JNEUROSCI.19-18-j0004.1999","volume":"19","author":"D Bagnol","year":"1999","unstructured":"Bagnol, D. et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19, RC26 (1999).","journal-title":"J. Neurosci."},{"key":"855_CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0896-6273(00)80829-6","volume":"24","author":"MA Cowley","year":"1999","unstructured":"Cowley, M. A. et al. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24, 155\u2013163 (1999).","journal-title":"Neuron"},{"key":"855_CR45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14051","volume":"520","author":"M Ghamari-Langroudi","year":"2015","unstructured":"Ghamari-Langroudi, M. et al. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons. Nature 520, 94\u201398 (2015).","journal-title":"Nature"},{"key":"855_CR46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nn.4442","volume":"20","author":"H Fenselau","year":"2017","unstructured":"Fenselau, H. et al. A rapidly acting glutamatergic ARC\u2192PVH satiety circuit postsynaptically regulated by \u03b1-MSH. Nat. Neurosci. 20, 42\u201351 (2017).","journal-title":"Nat. Neurosci."},{"key":"855_CR47","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1210\/en.2009-0804","volume":"150","author":"KP Skibicka","year":"2009","unstructured":"Skibicka, K. P. & Grill, H. J. Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins. Endocrinology 150, 5351\u20135361 (2009).","journal-title":"Endocrinology"},{"key":"855_CR48","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00451.2006","volume":"293","author":"G Li","year":"2007","unstructured":"Li, G. et al. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss. Am. J. Physiol. Endocrinol. Metab. 293, E252\u2013E258 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"855_CR49","unstructured":"Williams, D. L. Brainstem Melanocortin Receptor Contributions to Energy Balance. Dissertation, Univ. Pennsylvania https:\/\/repository.upenn.edu\/dissertations\/AAI3087483\/ (2003)."},{"key":"855_CR50","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1210\/en.2007-1754","volume":"149","author":"KP Skibicka","year":"2008","unstructured":"Skibicka, K. P. & Grill, H. J. Energetic responses are triggered by caudal brainstem melanocortin receptor stimulation and mediated by local sympathetic effector circuits. Endocrinology 149, 3605\u20133616 (2008).","journal-title":"Endocrinology"},{"key":"855_CR51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","volume":"363","author":"SR Smith","year":"2010","unstructured":"Smith, S. R. et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N. Engl. J. Med. 363, 245\u2013256 (2010).","journal-title":"N. Engl. J. Med."},{"key":"855_CR52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1185\/03007995.2013.794776","volume":"29","author":"SC Nigro","year":"2013","unstructured":"Nigro, S. C., Luon, D. & Baker, W. L. Lorcaserin: a novel serotonin 2C agonist for the treatment of obesity. Curr. Med. Res. Opin. 29, 839\u2013848 (2013).","journal-title":"Curr. Med. Res. Opin."},{"key":"855_CR53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","volume":"51","author":"LK Heisler","year":"2006","unstructured":"Heisler, L. K. et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51, 239\u2013249 (2006).","journal-title":"Neuron"},{"key":"855_CR54","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1523\/JNEUROSCI.5412-09.2010","volume":"30","author":"Y Xu","year":"2010","unstructured":"Xu, Y. et al. A serotonin and melanocortin circuit mediates d-fenfluramine anorexia. J. Neurosci. 30, 14630\u201314634 (2010).","journal-title":"J. Neurosci."},{"key":"855_CR55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","volume":"297","author":"LK Heisler","year":"2002","unstructured":"Heisler, L. K. et al. Activation of central melanocortin pathways by fenfluramine. Science 297, 609\u2013611 (2002).","journal-title":"Science"},{"key":"855_CR56","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jc.2010-1848","volume":"96","author":"CK Martin","year":"2011","unstructured":"Martin, C. K. et al. Lorcaserin, a 5-HT2C receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. J. Clin. Endocrinol. Metab. 96, 837\u2013845 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"855_CR57","unstructured":"US Food and Drug Administration. FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. FDA https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market (2020)."},{"key":"855_CR58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","volume":"314","author":"MJ Davies","year":"2015","unstructured":"Davies, M. J. et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA 314, 687\u2013699 (2015).","journal-title":"JAMA"},{"key":"855_CR59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer, X. et al. A randomized, controlled trial of 3.0\u2009mg of liraglutide in weight management. N. Engl. J. Med. 373, 11\u201322 (2015).","journal-title":"N. Engl. J. Med."},{"key":"855_CR60","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup, A. et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374, 1606\u20131616 (2009).","journal-title":"Lancet"},{"key":"855_CR61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmet.2019.07.008","volume":"28","author":"Z He","year":"2019","unstructured":"He, Z. et al. Direct and indirect effects of liraglutide on hypothalamic POMC and NPY\/AgRP neurons - implications for energy balance and glucose control. Mol. Metab. 28, 120\u2013134 (2019).","journal-title":"Mol. Metab."},{"key":"855_CR62","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","volume":"124","author":"A Secher","year":"2014","unstructured":"Secher, A. et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J. Clin. Invest. 124, 4473\u20134488 (2014).","journal-title":"J. Clin. Invest."},{"key":"855_CR63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/osp4.84","volume":"3","author":"A Mehta","year":"2017","unstructured":"Mehta, A., Marso, S. P. & Neeland, I. J. Liraglutide for weight management: a critical review of the evidence. Obes. Sci. Pract. 3, 3\u201314 (2017).","journal-title":"Obes. Sci. Pract."},{"key":"855_CR64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/obr.12839","volume":"20","author":"GA Christou","year":"2019","unstructured":"Christou, G. A., Katsiki, N., Blundell, J., Fruhbeck, G. & Kiortsis, D. N. Semaglutide as a promising antiobesity drug. Obes. Rev. 20, 805\u2013815 (2019).","journal-title":"Obes. Rev."},{"key":"855_CR65","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell, J. et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes. Metab. 19, 1242\u20131251 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"855_CR66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","volume":"5","author":"S Gabery","year":"2020","unstructured":"Gabery, S. et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5, e133429 (2020).","journal-title":"JCI Insight"},{"key":"855_CR67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27, 740\u2013756 (2018).","journal-title":"Cell Metab."},{"key":"855_CR68","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","volume":"310","author":"SE Kanoski","year":"2016","unstructured":"Kanoski, S. E., Hayes, M. R. & Skibicka, K. P. GLP-1 and weight loss: unraveling the diverse neural circuitry. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R885\u2013R895 (2016).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"855_CR69","doi-asserted-by":"crossref","first-page":"112870","DOI":"10.1016\/j.physbeh.2020.112870","volume":"220","author":"SM Fortin","year":"2020","unstructured":"Fortin, S. M., Chen, J. & Hayes, M. R. Hindbrain melanocortin 3\/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide. Physiol. Behav. 220, 112870 (2020).","journal-title":"Physiol. Behav."},{"key":"855_CR70","doi-asserted-by":"crossref","first-page":"288","DOI":"10.15252\/emmm.201404508","volume":"7","author":"C Clemmensen","year":"2015","unstructured":"Clemmensen, C. et al. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice. EMBO Mol. Med. 7, 288\u2013298 (2015).","journal-title":"EMBO Mol. Med."},{"key":"855_CR71","doi-asserted-by":"crossref","first-page":"eabd6434","DOI":"10.1126\/scitranslmed.abd6434","volume":"13","author":"P Sweeney","year":"2021","unstructured":"Sweeney, P. et al. The melanocortin-3 receptor is a pharmacological target for the regulation of anorexia. Sci. Transl. Med. 13, eabd6434 (2021).","journal-title":"Sci. Transl. Med."},{"key":"855_CR72","doi-asserted-by":"crossref","unstructured":"Naltrexone\/bupropion. Drugs R D 10, 25\u201332 (2010).","DOI":"10.2165\/11537710-000000000-00000"},{"key":"855_CR73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/clp.09.12","volume":"4","author":"D Hausenloy","year":"2017","unstructured":"Hausenloy, D. Contrave\u2122: novel treatment for obesity. Clin. Lipidol. 4, 279\u2013285 (2017).","journal-title":"Clin. Lipidol."},{"key":"855_CR74","doi-asserted-by":"crossref","unstructured":"Naltrexone\/bupropion for obesity. Drug. Ther. Bull. 55, 126\u2013129 (2017).","DOI":"10.1136\/dtb.2017.11.0550"},{"key":"855_CR75","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1115524","volume":"310","author":"S Luquet","year":"2005","unstructured":"Luquet, S., Perez, F. A., Hnasko, T. S. & Palmiter, R. D. NPY\/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310, 683\u2013685 (2005).","journal-title":"Science"},{"key":"855_CR76","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cell.2009.04.022","volume":"137","author":"Q Wu","year":"2009","unstructured":"Wu, Q., Boyle, M. P. & Palmiter, R. D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137, 1225\u20131234 (2009).","journal-title":"Cell"},{"key":"855_CR77","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1172\/JCI46229","volume":"121","author":"MJ Krashes","year":"2011","unstructured":"Krashes, M. J. et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424\u20131428 (2011).","journal-title":"J. Clin. Invest."},{"key":"855_CR78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nn.2739","volume":"14","author":"Y Aponte","year":"2011","unstructured":"Aponte, Y., Atasoy, D. & Sternson, S. M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 14, 351\u2013355 (2011).","journal-title":"Nat. Neurosci."},{"key":"855_CR79","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cell.2013.11.002","volume":"155","author":"JN Betley","year":"2013","unstructured":"Betley, J. N., Cao, Z. F., Ritola, K. D. & Sternson, S. M. Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell 155, 1337\u20131350 (2013).","journal-title":"Cell"},{"key":"855_CR80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature14416","volume":"521","author":"JN Betley","year":"2015","unstructured":"Betley, J. N. et al. Neurons for hunger and thirst transmit a negative-valence teaching signal. Nature 521, 180\u2013185 (2015).","journal-title":"Nature"},{"key":"855_CR81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature11270","volume":"488","author":"D Atasoy","year":"2012","unstructured":"Atasoy, D., Betley, J. N., Su, H. H. & Sternson, S. M. Deconstruction of a neural circuit for hunger. Nature 488, 172\u2013177 (2012).","journal-title":"Nature"},{"key":"855_CR82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44527","volume":"8","author":"CJ Burnett","year":"2019","unstructured":"Burnett, C. J. et al. Need-based prioritization of behavior. eLife 8, e44527 (2019).","journal-title":"eLife"},{"key":"855_CR83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuron.2016.08.032","volume":"92","author":"CJ Burnett","year":"2016","unstructured":"Burnett, C. J. et al. Hunger-driven motivational state competition. Neuron 92, 187\u2013201 (2016).","journal-title":"Neuron"},{"key":"855_CR84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cell.2018.02.057","volume":"173","author":"AL Alhadeff","year":"2018","unstructured":"Alhadeff, A. L. et al. A neural circuit for the suppression of pain by a competing need state. Cell 173, 140\u2013152 (2018).","journal-title":"Cell"},{"key":"855_CR85","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nn.4274","volume":"19","author":"SL Padilla","year":"2016","unstructured":"Padilla, S. L. et al. Agouti-related peptide neural circuits mediate adaptive behaviors in the starved state. Nat. Neurosci. 19, 734\u2013741 (2016).","journal-title":"Nat. Neurosci."},{"key":"855_CR86","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nature10899","volume":"483","author":"Q Wu","year":"2012","unstructured":"Wu, Q., Clark, M. S. & Palmiter, R. D. Deciphering a neuronal circuit that mediates appetite. Nature 483, 594\u2013597 (2012).","journal-title":"Nature"},{"key":"855_CR87","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1073\/pnas.1621065114","volume":"114","author":"SL Padilla","year":"2017","unstructured":"Padilla, S. L. et al. AgRP to Kiss1 neuron signaling links nutritional state and fertility. Proc. Natl Acad. Sci. USA 114, 2413\u20132418 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR88","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2015.02.024","volume":"160","author":"MO Dietrich","year":"2015","unstructured":"Dietrich, M. O., Zimmer, M. R., Bober, J. & Horvath, T. L. Hypothalamic Agrp neurons drive stereotypic behaviors beyond feeding. Cell 160, 1222\u20131232 (2015).","journal-title":"Cell"},{"key":"855_CR89","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nn.4011","volume":"18","author":"AS Garfield","year":"2015","unstructured":"Garfield, A. S. et al. A neural basis for melanocortin-4 receptor-regulated appetite. Nat. Neurosci. 18, 863\u2013871 (2015).","journal-title":"Nat. Neurosci."},{"key":"855_CR90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2016.04.006","volume":"23","author":"CA Campos","year":"2016","unstructured":"Campos, C. A., Bowen, A. J., Schwartz, M. W. & Palmiter, R. D. Parabrachial CGRP neurons control meal termination. Cell Metab. 23, 811\u2013820 (2016).","journal-title":"Cell Metab."},{"key":"855_CR91","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0712062105","volume":"105","author":"Q Wu","year":"2008","unstructured":"Wu, Q., Howell, M. P., Cowley, M. A. & Palmiter, R. D. Starvation after AgRP neuron ablation is independent of melanocortin signaling. Proc. Natl Acad. Sci. USA 105, 2687\u20132692 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR92","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2013.09.009","volume":"18","author":"MJ Krashes","year":"2013","unstructured":"Krashes, M. J., Shah, B. P., Koda, S. & Lowell, B. B. Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 18, 588\u2013595 (2013).","journal-title":"Cell Metab."},{"key":"855_CR93","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14291-3","volume":"11","author":"L Engstrom Ruud","year":"2020","unstructured":"Engstrom Ruud, L., Pereira, M. M. A., de Solis, A. J., Fenselau, H. & Bruning, J. C. NPY mediates the rapid feeding and glucose metabolism regulatory functions of AgRP neurons. Nat. Commun. 11, 442 (2020).","journal-title":"Nat. Commun."},{"key":"855_CR94","volume":"8","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Sustained NPY signaling enables AgRP neurons to drive feeding. eLife 8, e46348 (2019).","journal-title":"eLife"},{"key":"855_CR95","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1152\/ajpregu.2000.279.1.R47","volume":"279","author":"MM Hagan","year":"2000","unstructured":"Hagan, M. M. et al. Long-term orexigenic effects of AgRP-(83\u2013132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R47\u2013R52 (2000).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"855_CR96","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.peptides.2004.11.036","volume":"26","author":"LE Pritchard","year":"2005","unstructured":"Pritchard, L. E. & White, A. Agouti-related protein: more than a melanocortin-4 receptor antagonist? Peptides 26, 1759\u20131770 (2005).","journal-title":"Peptides"},{"key":"855_CR97","volume":"13","author":"M Cheng","year":"2018","unstructured":"Cheng, M. et al. Computational analyses of obesity associated loci generated by genome-wide association studies. PLoS One 13, e0199987 (2018).","journal-title":"PLoS One"},{"key":"855_CR98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007603","volume":"15","author":"F Riveros-McKay","year":"2019","unstructured":"Riveros-McKay, F. et al. Genetic architecture of human thinness compared to severe obesity. PLoS Genet. 15, e1007603 (2019).","journal-title":"PLoS Genet."},{"key":"855_CR99","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1210\/jc.2011-3259","volume":"97","author":"A Alkemade","year":"2012","unstructured":"Alkemade, A. et al. AgRP and NPY expression in the human hypothalamic infundibular nucleus correlate with body mass index, whereas changes in alphaMSH are related to type 2 diabetes. J. Clin. Endocrinol. Metab. 97, E925\u2013E933 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"855_CR100","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00018-008-8104-4","volume":"65","author":"O Ilnytska","year":"2008","unstructured":"Ilnytska, O. & Argyropoulos, G. The role of the Agouti-related protein in energy balance regulation. Cell Mol. Life Sci. 65, 2721\u20132731 (2008).","journal-title":"Cell Mol. Life Sci."},{"key":"855_CR101","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1096\/fj.06-7503com","volume":"21","author":"Y Song","year":"2007","unstructured":"Song, Y. & Cone, R. D. Creation of a genetic model of obesity in a teleost. FASEB J. 21, 2042\u20132049 (2007).","journal-title":"FASEB J."},{"key":"855_CR102","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnut.2019.00190","volume":"6","author":"M Mequinion","year":"2019","unstructured":"Mequinion, M., Foldi, C. J. & Andrews, Z. B. The ghrelin-AgRP neuron nexus in anorexia nervosa: implications for metabolic and behavioral adaptations. Front. Nutr. 6, 190 (2019).","journal-title":"Front. Nutr."},{"key":"855_CR103","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","volume":"4","author":"TD Muller","year":"2015","unstructured":"Muller, T. D. et al. Ghrelin. Mol. Metab. 4, 437\u2013460 (2015).","journal-title":"Mol. Metab."},{"key":"855_CR104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13539-010-0012-4","volume":"1","author":"TD Muller","year":"2010","unstructured":"Muller, T. D., Perez-Tilve, D., Tong, J., Pfluger, P. T. & Tschop, M. H. Ghrelin and its potential in the treatment of eating\/wasting disorders and cachexia. J. Cachexia Sarcopenia Muscle 1, 159\u2013167 (2010).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"855_CR105","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","volume":"50","author":"DE Cummings","year":"2001","unstructured":"Cummings, D. E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714\u20131719 (2001).","journal-title":"Diabetes"},{"key":"855_CR106","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tschop","year":"2000","unstructured":"Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908\u2013913 (2000).","journal-title":"Nature"},{"key":"855_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-10-0099","volume":"163","author":"A Romero","year":"2010","unstructured":"Romero, A. et al. GOAT: the master switch for the ghrelin system? Eur. J. Endocrinol. 163, 1\u20138 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"855_CR108","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","volume":"37","author":"MA Cowley","year":"2003","unstructured":"Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649\u2013661 (2003).","journal-title":"Neuron"},{"key":"855_CR109","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194\u2013198 (2001).","journal-title":"Nature"},{"key":"855_CR110","doi-asserted-by":"crossref","first-page":"17m11585","DOI":"10.4088\/JCP.17m11585","volume":"79","author":"PK Fazeli","year":"2018","unstructured":"Fazeli, P. K. et al. Treatment with a ghrelin agonist in outpatient women with anorexia nervosa: a randomized clinical trial. J. Clin. Psychiatry 79, 17m11585 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"855_CR111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ijo.2013.80","volume":"38","author":"L Fani","year":"2014","unstructured":"Fani, L., Bak, S., Delhanty, P., van Rossum, E. F. & van den Akker, E. L. The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options. Int. J. Obes. 38, 163\u2013169 (2014).","journal-title":"Int. J. Obes."},{"key":"855_CR112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2015.02.023","volume":"161","author":"L Gautron","year":"2015","unstructured":"Gautron, L., Elmquist, J. K. & Williams, K. W. Neural control of energy balance: translating circuits to therapies. Cell 161, 133\u2013145 (2015).","journal-title":"Cell"},{"key":"855_CR113","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/phar.1639","volume":"35","author":"WA Nuffer","year":"2015","unstructured":"Nuffer, W. A. & Trujillo, J. M. Liraglutide: a new option for the treatment of obesity. Pharmacotherapy 35, 926\u2013934 (2015).","journal-title":"Pharmacotherapy"},{"key":"855_CR114","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1039\/c1cc11817j","volume":"47","author":"AL Garner","year":"2011","unstructured":"Garner, A. L. & Janda, K. D. A small molecule antagonist of ghrelin O-acyltransferase (GOAT). Chem. Commun. 47, 7512\u20137514 (2011).","journal-title":"Chem. Commun."},{"key":"855_CR115","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/cne.25379","volume":"530","author":"MN Bedenbaugh","year":"2022","unstructured":"Bedenbaugh, M. N. et al. Organization of neural systems expressing melanocortin-3 receptors in the mouse brain: evidence for sexual dimorphism. J. Comp. Neurol. 530, 2835\u20132851 (2022).","journal-title":"J. Comp. Neurol."},{"key":"855_CR116","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/en.2013-2049","volume":"155","author":"RN Lippert","year":"2014","unstructured":"Lippert, R. N., Ellacott, K. L. & Cone, R. D. Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice. Endocrinology 155, 1718\u20131727 (2014).","journal-title":"Endocrinology"},{"key":"855_CR117","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/JP277193","volume":"597","author":"KS West","year":"2019","unstructured":"West, K. S., Lu, C., Olson, D. P. & Roseberry, A. G. Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area. J. Physiol. 597, 3217\u20133232 (2019).","journal-title":"J. Physiol."},{"key":"855_CR118","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/npp.2016.19","volume":"41","author":"R Pandit","year":"2016","unstructured":"Pandit, R. et al. Melanocortin 3 receptor signaling in midbrain dopamine neurons increases the motivation for food reward. Neuropsychopharmacology 41, 2241\u20132251 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"855_CR119","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnins.2017.00128","volume":"11","author":"AA Butler","year":"2017","unstructured":"Butler, A. A. et al. A life without hunger: the ups (and downs) to modulating melanocortin-3 receptor signaling. Front. Neurosci. 11, 128 (2017).","journal-title":"Front. Neurosci."},{"key":"855_CR120","doi-asserted-by":"crossref","first-page":"eaat0866","DOI":"10.1126\/sciadv.aat0866","volume":"4","author":"M Ghamari-Langroudi","year":"2018","unstructured":"Ghamari-Langroudi, M. et al. Regulation of energy rheostasis by the melanocortin-3 receptor. Sci. Adv. 4, eaat0866 (2018).","journal-title":"Sci. Adv."},{"key":"855_CR121","volume":"6","author":"P You","year":"2016","unstructured":"You, P. et al. Effects of melanocortin 3 and 4 receptor deficiency on energy homeostasis in rats. Sci. Rep. 6, 34938 (2016).","journal-title":"Sci. Rep."},{"key":"855_CR122","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/endo.141.9.7791","volume":"141","author":"AA Butler","year":"2000","unstructured":"Butler, A. A. et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518\u20133521 (2000).","journal-title":"Endocrinology"},{"key":"855_CR123","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/79254","volume":"26","author":"AS Chen","year":"2000","unstructured":"Chen, A. S. et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97\u2013102 (2000).","journal-title":"Nat. Genet."},{"key":"855_CR124","doi-asserted-by":"crossref","first-page":"E1489","DOI":"10.1073\/pnas.1201994109","volume":"109","author":"BJ Renquist","year":"2012","unstructured":"Renquist, B. J. et al. Melanocortin-3 receptor regulates the normal fasting response. Proc. Natl Acad. Sci. USA 109, E1489\u2013E1498 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR125","doi-asserted-by":"crossref","first-page":"12946","DOI":"10.1523\/JNEUROSCI.3615-08.2008","volume":"28","author":"GM Sutton","year":"2008","unstructured":"Sutton, G. M. et al. The melanocortin-3 receptor is required for entrainment to meal intake. J. Neurosci. 28, 12946\u201312955 (2008).","journal-title":"J. Neurosci."},{"key":"855_CR126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1601-183X.2012.00766.x","volume":"11","author":"K Begriche","year":"2012","unstructured":"Begriche, K. et al. Melanocortin-3 receptors are involved in adaptation to restricted feeding. Genes Brain Behav. 11, 291\u2013302 (2012).","journal-title":"Genes Brain Behav."},{"key":"855_CR127","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41586-021-04088-9","volume":"599","author":"BYH Lam","year":"2021","unstructured":"Lam, B. Y. H. et al. MC3R links nutritional state to childhood growth and the timing of puberty. Nature 599, 436\u2013441 (2021).","journal-title":"Nature"},{"key":"855_CR128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.tins.2013.05.003","volume":"36","author":"JW Sohn","year":"2013","unstructured":"Sohn, J. W., Elmquist, J. K. & Williams, K. W. Neuronal circuits that regulate feeding behavior and metabolism. Trends Neurosci. 36, 504\u2013512 (2013).","journal-title":"Trends Neurosci."},{"key":"855_CR129","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/en.2002-221099","volume":"144","author":"DL Marks","year":"2003","unstructured":"Marks, D. L., Butler, A. A., Turner, R., Brookhart, G. & Cone, R. D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology 144, 1513\u20131523 (2003).","journal-title":"Endocrinology"},{"key":"855_CR130","unstructured":"Marks, D. L. in Energy Metabolism and Obesity: Research and Clinical Applications (ed P. A. Donohoue) 59\u201368 (Humana, 2008)."},{"key":"855_CR131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2005.08.035","volume":"123","author":"N Balthasar","year":"2005","unstructured":"Balthasar, N. et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493\u2013505 (2005).","journal-title":"Cell"},{"key":"855_CR132","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.1407843111","volume":"111","author":"BP Shah","year":"2014","unstructured":"Shah, B. P. et al. MC4R-expressing glutamatergic neurons in the paraventricular hypothalamus regulate feeding and are synaptically connected to the parabrachial nucleus. Proc. Natl Acad. Sci. USA 111, 13193\u201313198 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR133","first-page":"40","volume":"126","author":"YQ Li","year":"2016","unstructured":"Li, Y. Q. et al. G(q\/11)\u03b1 and G(s)\u03b1 mediate distinct physiological responses to central melanocortins. J. Clin. Invest. 126, 40\u201349 (2016).","journal-title":"J. Clin. Invest."},{"key":"855_CR134","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0006-8993(98)00837-3","volume":"809","author":"SQ Giraudo","year":"1998","unstructured":"Giraudo, S. Q., Billington, C. J. & Levine, A. S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 809, 302\u2013306 (1998).","journal-title":"Brain Res."},{"key":"855_CR135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cmet.2018.10.016","volume":"29","author":"C Li","year":"2018","unstructured":"Li, C. et al. Defined paraventricular hypothalamic populations exhibit differential responses to food contingent on caloric state. Cell Metab. 29, 681\u2013694 (2018).","journal-title":"Cell Metab."},{"key":"855_CR136","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2012.12.022","volume":"152","author":"JW Sohn","year":"2013","unstructured":"Sohn, J. W. et al. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152, 612\u2013619 (2013).","journal-title":"Cell"},{"key":"855_CR137","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nn.3737","volume":"17","author":"ED Berglund","year":"2014","unstructured":"Berglund, E. D. et al. Melanocortin 4 receptors in autonomic neurons regulate thermogenesis and glycemia. Nat. Neurosci. 17, 911\u2013913 (2014).","journal-title":"Nat. Neurosci."},{"key":"855_CR138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2011.01.010","volume":"13","author":"J Rossi","year":"2011","unstructured":"Rossi, J. et al. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 13, 195\u2013204 (2011).","journal-title":"Cell Metab."},{"key":"855_CR139","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1523\/JNEUROSCI.18-23-10128.1998","volume":"18","author":"HJ Grill","year":"1998","unstructured":"Grill, H. J., Ginsberg, A. B., Seeley, R. J. & Kaplan, J. M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18, 10128\u201310135 (1998).","journal-title":"J. Neurosci."},{"key":"855_CR140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.aaz8995","volume":"368","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand binding. Science 368, 428\u2013433 (2020).","journal-title":"Science"},{"key":"855_CR141","volume":"31","author":"EJP Anderson","year":"2019","unstructured":"Anderson, E. J. P. et al. Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor. J. Neuroendocrinol. 31, e12670 (2019).","journal-title":"J. Neuroendocrinol."},{"key":"855_CR142","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00747-6","volume":"8","author":"D Srisai","year":"2017","unstructured":"Srisai, D. et al. MRAP2 regulates ghrelin receptor signaling and hunger sensing. Nat. Commun. 8, 713 (2017).","journal-title":"Nat. Commun."},{"key":"855_CR143","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbamcr.2017.09.008","volume":"1864","author":"AAJ Rouault","year":"2017","unstructured":"Rouault, A. A. J., Lee, A. A. & Sebag, J. A. Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling. Biochim. Biophys. Acta 1864, 2322\u20132329 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"855_CR144","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1126\/science.1232995","volume":"341","author":"JA Sebag","year":"2013","unstructured":"Sebag, J. A., Zhang, C., Hinkle, P. M., Bradshaw, A. M. & Cone, R. D. Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish. Science 341, 278\u2013281 (2013).","journal-title":"Science"},{"key":"855_CR145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1126\/science.1233000","volume":"341","author":"M Asai","year":"2013","unstructured":"Asai, M. et al. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 341, 275\u2013278 (2013).","journal-title":"Science"},{"key":"855_CR146","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","volume":"177","author":"LA Lotta","year":"2019","unstructured":"Lotta, L. A. et al. Human gain-of-function MC4R variants show signaling bias and protect against obesity. Cell 177, 597\u2013607 (2019).","journal-title":"Cell"},{"key":"855_CR147","doi-asserted-by":"crossref","first-page":"108862","DOI":"10.1016\/j.celrep.2021.108862","volume":"34","author":"B Brouwers","year":"2021","unstructured":"Brouwers, B. et al. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation. Cell Rep. 34, 108862 (2021).","journal-title":"Cell Rep."},{"key":"855_CR148","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12795","volume":"31","author":"T Gillyard","year":"2019","unstructured":"Gillyard, T., Fowler, K., Williams, S. Y. & Cone, R. D. Obesity-associated mutant melanocortin-4 receptors with normal G\u03b1s coupling frequently exhibit other discoverable pharmacological and biochemical defects. J. Neuroendocrinol. 31, e12795 (2019).","journal-title":"J. Neuroendocrinol."},{"key":"855_CR149","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.7150\/ijbs.10359","volume":"10","author":"S He","year":"2014","unstructured":"He, S. & Tao, Y. X. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene. Int. J. Biol. Sci. 10, 1128\u20131137 (2014).","journal-title":"Int. J. Biol. Sci."},{"key":"855_CR150","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.172378699","volume":"99","author":"LH Van der Ploeg","year":"2002","unstructured":"Van der Ploeg, L. H. et al. A role for the melanocortin 4 receptor in sexual function. Proc. Natl Acad. Sci. USA 99, 11381\u201311386 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"855_CR151","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2174\/156802607780906564","volume":"7","author":"SH King","year":"2007","unstructured":"King, S. H. et al. Melanocortin receptors, melanotropic peptides and penile erection. Curr. Top. Med. Chem. 7, 1098\u20131106 (2007).","journal-title":"Curr. Top. Med. Chem."},{"key":"855_CR152","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.peptides.2005.01.023","volume":"26","author":"ME Hadley","year":"2005","unstructured":"Hadley, M. E. Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides 26, 1687\u20131689 (2005).","journal-title":"Peptides"},{"key":"855_CR153","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.peptides.2005.01.029","volume":"27","author":"ME Hadley","year":"2006","unstructured":"Hadley, M. E. & Dorr, R. T. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides 27, 921\u2013930 (2006).","journal-title":"Peptides"},{"key":"855_CR154","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s40265-019-01187-w","volume":"79","author":"S Dhillon","year":"2019","unstructured":"Dhillon, S. & Keam, S. J. Bremelanotide: first approval. Drugs 79, 1599\u20131606 (2019).","journal-title":"Drugs"},{"key":"855_CR155","unstructured":"Bremelanotide (Vyleesi) for hypoactive sexual desire disorder. Med. Lett. Drugs Ther. 61, 114\u2013116 (2019)."},{"key":"855_CR156","first-page":"407","volume":"38","author":"SA Huang","year":"2013","unstructured":"Huang, S. A. & Lie, J. D. Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T 38, 407\u2013419 (2013).","journal-title":"P T"},{"key":"855_CR157","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2007.00610.x","volume":"4","author":"J Pfaus","year":"2007","unstructured":"Pfaus, J., Giuliano, F. & Gelez, H. Bremelanotide: an overview of preclinical CNS effects on female sexual function. J. Sex. Med. 4, 269\u2013279 (2007).","journal-title":"J. Sex. Med."},{"key":"855_CR158","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/AOG.0000000000003500","volume":"134","author":"SA Kingsberg","year":"2019","unstructured":"Kingsberg, S. A. et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet. Gynecol. 134, 899\u2013908 (2019).","journal-title":"Obstet. Gynecol."},{"key":"855_CR159","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1060028019899152","volume":"54","author":"D Mayer","year":"2020","unstructured":"Mayer, D. & Lynch, S. E. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder. Ann. Pharmacother. 54, 684\u2013690 (2020).","journal-title":"Ann. Pharmacother."},{"key":"855_CR160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2009-0037","volume":"31","author":"YX Tao","year":"2010","unstructured":"Tao, Y. X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 31, 506\u2013543 (2010).","journal-title":"Endocr. Rev."},{"key":"855_CR161","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","volume":"24","author":"K Clement","year":"2018","unstructured":"Clement, K. et al. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat. Med. 24, 551\u2013555 (2018).","journal-title":"Nat. Med."},{"key":"855_CR162","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","volume":"375","author":"P Kuhnen","year":"2016","unstructured":"Kuhnen, P. et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N. Engl. J. Med. 375, 240\u2013246 (2016).","journal-title":"N. Engl. J. Med."},{"key":"855_CR163","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","volume":"10","author":"AM Haqq","year":"2022","unstructured":"Haqq, A. M. et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrom syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diabetes Endocrinol. 10, 859\u2013868 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"855_CR164","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.conctc.2021.100780","volume":"22","author":"RM Haws","year":"2021","unstructured":"Haws, R. M. et al. The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstr\u00f6m syndrome: phase 3 trial design. Contemp. Clin. Trials Commun. 22, 100780 (2021).","journal-title":"Contemp. Clin. Trials Commun."},{"key":"855_CR165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/ddg016","volume":"12","author":"C Lubrano-Berthelier","year":"2003","unstructured":"Lubrano-Berthelier, C. et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 12, 145\u2013153 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"855_CR166","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/diabetes.51.5.1337","volume":"51","author":"DD Pierroz","year":"2002","unstructured":"Pierroz, D. D. et al. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51, 1337\u20131345 (2002).","journal-title":"Diabetes"},{"key":"855_CR167","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/bph.13540","volume":"173","author":"JM Bischof","year":"2016","unstructured":"Bischof, J. M., Van Der Ploeg, L. H., Colmers, W. F. & Wevrick, R. Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist. Br. J. Pharmacol. 173, 2614\u20132621 (2016).","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 1","key":"855_CR168","doi-asserted-by":"crossref","first-page":"MON-LB019","DOI":"10.1210\/js.2019-MON-LB019","volume":"3","author":"E Stephenson","year":"2019","unstructured":"Stephenson, E., Stayton, A. & Han, J. Setmelanotide (RM-493) reduces food intake and rapidly induces weight loss in a mouse model of Alstr\u00f6m syndrome [abstract]. J. Endocr. Soc. 3(Suppl. 1), MON-LB019 (2019).","journal-title":"J. Endocr. Soc."},{"key":"855_CR169","unstructured":"Center for Drug Evaluation & Research. FDA approves treatment for weight management in patients with Bardet-Biedl syndrome aged 6 or older. FDA https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-weight-management-patients-bardet-biedl-syndrome-aged-6-or-older (2022)."},{"key":"855_CR170","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","volume":"6","author":"TH Collet","year":"2017","unstructured":"Collet, T. H. et al. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. Mol. Metab. 6, 1321\u20131329 (2017).","journal-title":"Mol. Metab."},{"key":"855_CR171","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/molecules24101892","volume":"24","author":"S Sharma","year":"2019","unstructured":"Sharma, S. et al. Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation. Molecules 24, 1892 (2019).","journal-title":"Molecules"},{"key":"855_CR172","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000516282","volume":"34","author":"V Kanti","year":"2021","unstructured":"Kanti, V. et al. A Melanocortin-4 receptor agonist induces skin and hair pigmentation in patients with monogenic mutations in the leptin-melanocortin pathway. Skin. Pharmacol. Physiol. 34, 307\u2013316 (2021).","journal-title":"Skin. Pharmacol. Physiol."},{"key":"855_CR173","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tem.2020.04.006","volume":"31","author":"AK Sutton","year":"2020","unstructured":"Sutton, A. K. & Krashes, M. J. Integrating hunger with rival motivations. Trends Endocrinol. Metab. 31, 495\u2013507 (2020).","journal-title":"Trends Endocrinol. Metab."},{"key":"855_CR174","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.peptides.2005.01.025","volume":"27","author":"DL Marks","year":"2006","unstructured":"Marks, D. L., Hruby, V., Brookhart, G. & Cone, R. D. The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 27, 259\u2013264 (2006).","journal-title":"Peptides"},{"key":"855_CR175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.peptides.2007.11.005","volume":"29","author":"M Lee","year":"2008","unstructured":"Lee, M. et al. Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 29, 440\u2013447 (2008).","journal-title":"Peptides"},{"key":"855_CR176","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/B978-0-444-52002-9.00026-7","volume":"106","author":"B Herpertz-Dahlmann","year":"2012","unstructured":"Herpertz-Dahlmann, B., Holtkamp, K. & Konrad, K. Eating disorders: anorexia and bulimia nervosa. Handb. Clin. Neurol. 106, 447\u2013462 (2012).","journal-title":"Handb. Clin. Neurol."},{"key":"855_CR177","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI97854","volume":"128","author":"AM Klawonn","year":"2018","unstructured":"Klawonn, A. M. et al. Motivational valence is determined by striatal melanocortin 4 receptors. J. Clin. Invest. 128, 3160\u20133170 (2018).","journal-title":"J. Clin. Invest."},{"key":"855_CR178","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature11160","volume":"487","author":"BK Lim","year":"2012","unstructured":"Lim, B. K., Huang, K. W., Grueter, B. A., Rothwell, P. E. & Malenka, R. C. Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 487, 183\u2013189 (2012).","journal-title":"Nature"},{"key":"855_CR179","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.peptides.2004.11.029","volume":"26","author":"S Chaki","year":"2005","unstructured":"Chaki, S. & Okuyama, S. Involvement of melanocortin-4 receptor in anxiety and depression. Peptides 26, 1952\u20131964 (2005).","journal-title":"Peptides"},{"key":"855_CR180","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1021\/acs.jmedchem.2c02012","volume":"66","author":"MR Garnsey","year":"2023","unstructured":"Garnsey, M. R. et al. Discovery of the potent and selective MC4R antagonist PF-07258669 for the potential treatment of appetite loss. J. Med. Chem. 66, 3195\u20133211 (2023).","journal-title":"J. Med. Chem."},{"key":"855_CR181","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05113940 (2022)."},{"key":"855_CR182","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/acsptsci.1c00270","volume":"5","author":"KA Gruber","year":"2022","unstructured":"Gruber, K. A. et al. Development of a therapeutic peptide for cachexia suggests a platform approach for drug-like peptides. ACS Pharmacol. Transl. Sci. 5, 344\u2013361 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"855_CR183","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.abf7958","volume":"372","author":"H Israeli","year":"2021","unstructured":"Israeli, H. et al. Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling. Science 372, 808\u2013814 (2021).","journal-title":"Science"},{"key":"855_CR184","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41422-021-00569-8","volume":"31","author":"NA Heyder","year":"2021","unstructured":"Heyder, N. A. et al. Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-\u03b1-MSH and setmelanotide. Cell Res. 31, 1176\u20131189 (2021).","journal-title":"Cell Res."},{"key":"855_CR185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","volume":"373","author":"JG Langendonk","year":"2015","unstructured":"Langendonk, J. G. et al. Afamelanotide for erythropoietic protoporphyria. N. Engl. J. Med. 373, 48\u201359 (2015).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00855-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T09:06:04Z","timestamp":1691571964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00855-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":185,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1038\/s41574-023-00855-y","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"18 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.S., L.E.G., R.D.C. and the\u00a0University of Michigan\u00a0hold equity in Courage Therapeutics Inc. and are inventors of intellectual property optioned to Courage Therapeutics Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}